May 22, 2024
Researchers at UC San Diego have found that nearly 3% of healthy adolescents use commercial CBD products, many of which contain higher levels of THC than advertised.
July 14, 2020
Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.
April 26, 2018
Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder.
October 10, 2019
The Center for Medicinal Cannabis Research at University of California San Diego School of Medicine announces $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
February 1, 2022
The National Football League is funding a novel clinical trial by UC San Diego researchers to assess whether cannabis or CBD provide any post-game pain relief caused by athletic injury. Trial participants will be professional rugby players.
April 26, 2018
Is CBD a Remedy for Autism? TBD. Novel study, funded by largest gift of its type in U.S., will explore whether cannabis compound eases severe symptoms of autism Cannabidiol (CBD) is one of dozens of compounds found in the cannabis plant. But unlike its more notorious chemical cousin tetrahydrocannabinol or…
September 18, 2018
Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor (ET). Currently, ET is treated using repurposed medications originally developed for high blood pressure or…
May 19, 2021
UC San Diego Health is conducting the first known randomized, double-blind, placebo-controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.
October 10, 2019
…of medical cannabis and CBD,” said Dr. Igor Grant, Distinguished Professor in the Department of Psychiatry and CMCR director. “There is a hope that it could be yet another useful agent in some of these conditions, which are difficult to treat or disabling.” The cannabis plant produces a number of…
January 13, 2020
University of California San Diego School of Medicine researchers identified how THC from marijuana accelerates cancer growth in patients with human papillomavirus (HPV)-positive head and neck cancer.
